Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
H.B. Fuller Company announced its third quarter 2026 operating results on September 23, 2026, disclosing net revenue of $938 million (up 5.2% YoY), net income of $79 million, adjusted EBITDA of $187 million (up 9% YoY), and adjusted diluted EPS of $1.52 (up 21% YoY). The press release is furnished as Exhibit 99.1 and includes detailed financial statements, segment performance, balance sheet metrics, and updated fiscal 2026 guidance. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
This is a clear earnings release for Trio-Tech International's fiscal year and fourth quarter ended June 30, 2026. The press release (Exhibit 99.1) discloses comprehensive financial results including revenue of $62.6 million (72% growth), gross profit, operating results, and earnings per share, along with forward-looking guidance and backlog information. The Item 2.02 disclosure explicitly states the company "issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026," which is the hallmark of an earnings_release event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-24
Item 5.02
Michael L. Regina was appointed to the Board of Directors of Parke Bancorp, Inc. on September 22, 2026, bringing commercial real estate development and finance expertise. He was appointed to both the holding company board and Parke Bank's board.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-24
Item 5.02
The Board approved stock awards of 250,000 shares to CEO Desmond Wheatley and 90,000 shares to CFO Lisa A. Potok under the 2021 Equity Incentive Plan as bonus compensation for fiscal year 2025 performance. This is a direct disclosure of compensatory arrangements for named executives, fitting the exec_compensation category. The materiality is high given the substantial share quantities awarded to senior officers.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
Item 2.02
ICF International announced the timing and details of its third quarter 2026 earnings release scheduled for November 5, 2026, after market close, along with a webcast conference call. The press release (Exhibit 99.1) explicitly states "ICF...will release its third quarter 2026 results on Thursday, November 5, 2026, after the market close" and provides registration and access details for the earnings call. This is a standard earnings announcement disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-24
Item 1.01
Patriot National Bancorp entered into a securities purchase agreement to issue 4,782,608 shares of voting common stock and 956,522 warrants in a registered direct offering to accredited investors, raising approximately $5.5 million in gross proceeds. This is a dilutive equity issuance to raise capital, characteristic of a PIPE or registered direct offering, which materially affects existing shareholders through dilution and is a key financing event for a small-cap bank holding company.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-24
The 6-K discloses that Tantech regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after previously falling below $1.00 per share for 30 consecutive business days on March 26, 2026. The notification on September 21, 2026 confirms the Company has satisfied the 180-day cure period and is no longer at risk of delisting. This resolves a material delisting risk that threatened the Company's continued listing on Nasdaq.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-24
Item 5.02
The filing discloses the appointment of William "Billy" Skrobacz, Jr. as President of Capitol Federal Financial, Inc. and Capitol Federal Savings Bank, effective October 1, 2026. While the disclosure also includes compensatory details (base salary of $460,000 and 22,500 shares vesting over five years), the principal action is the appointment to a significant executive role responsible for day-to-day operations. This is a material executive appointment that would affect investor assessment of the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-24
Christopher Jones voluntarily resigned from all employment and officer/director positions on September 22, 2026. While the filing also discloses a board appointment (Jay Heller) and a separation agreement with financial terms, the principal disclosed action centers on Jones's departure. The separation agreement details ($100K severance, $1.44M loan repayment restructuring, $500K franchise buyback) are material consequences of the departure, not independent compensation arrangements.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-24
EX-99.1
The exhibit announces the results of an extraordinary general meeting of shareholders where Cloopen's shareholders voted to approve a merger agreement with SpringX Holdings Limited and its subsidiaries. The vote passed with approximately 99.98% approval. This is a shareholder vote result on a material transaction (the merger itself), which is the core disclosure event here. While the merger is also a material acquisition/change of control, the exhibit's primary disclosure is the shareholder vote outcome and approval, making shareholder_vote_results the most precise classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-24
Newton Golf Company issued 232,202 shares of common stock in exchange for warrant repurchases on September 21-22, 2026. Item 3.02 explicitly discloses this as an unregistered sale of equity securities exempt under Section 3(a)(9). The filing also grants warrant holders a 12-month pro rata purchase option on future equity issuances up to 10% of any offering, which is a material dilutive commitment. This is a classic dilutive issuance event involving unregistered equity sales and future dilution rights.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-24
Item 1.01
Brightline Interactive entered into securities purchase agreements on September 23, 2026, to sell 1,785,711 units (each comprising one share of common stock and one warrant) for $0.70 per unit, generating $1.25 million in gross proceeds. This is a classic private investment in public equity (PIPE) transaction—an unregistered sale of equity securities to raise capital. The filing explicitly discloses reliance on Section 4(a)(2) exemption from Securities Act registration (Item 3.02), and the company commits to file a registration statement within 30 days. The dilutive nature is evident: new shares and warrants are being issued at a price ($0.70) described as "above the Company's closing share price on September 23, 2026," yet the issuance of 1.78+ million units will dilute existing shareholders. This is a material capital-raising event typical of small- to mid-cap issuers.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-24
The Company completed a private placement on September 3, 2026, issuing 15,000,000 Class A ordinary shares at $1.266 per share plus warrants to purchase 15,000,000 additional shares at $0.50 per share, for an aggregate of $18.99 million. This is a classic dilutive equity issuance to non-U.S. investors that materially increases share count and is a strong signal of capital-raising activity typical of small- and mid-cap issuers.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-24
Newton Golf Company entered into an Assignment and Assumption Agreement on September 23, 2026, acquiring an exclusive option to acquire 100% ownership of the Pole Canyon Project (16 mining claims, ~330 acres in Nevada) from Spartan Crest Capital Corp. and Cannon Bridge Mining Services. In exchange, the Company issued shares equal to 19.9% of outstanding shares to Spartan Crest's designees, assumed $365,000 in remaining payment obligations, and granted Spartan Crest board and executive officer designation rights. This constitutes a material acquisition activity under Item 1.01, involving significant equity dilution and assumption of substantial financial obligations.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-24
NextTrip announced the launch of "NextTrip LIVE," a new destination entertainment platform developed in partnership with YADA Commerce Inc. and Loaded Dice Commerce Group. The filing discloses a strategic business initiative combining live entertainment, destination travel, and NextTrip's travel booking capabilities, with the inaugural event scheduled for November 2026 in Riviera Cancún. This represents a material operational and strategic development leveraging the Company's June 2026 acquisition of YADA, but does not fit the specific categories of M&A activity (the YADA acquisition was previously disclosed), earnings release, executive changes, or other named event types. The disclosure is material as it describes a new revenue-generating business line and strategic direction for the company.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.1
This exhibit is a press release announcing Uxin's unaudited financial results for the quarter ended June 30, 2026. It discloses quarterly revenue (RMB1,151.2 million), gross margin (-0.7%), operating loss (RMB151.9 million), and net loss (RMB178.4 million), along with transaction volumes and forward guidance. The document explicitly states "Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026" and includes management commentary on performance. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-24
HCW Biologics entered into a Securities Purchase Agreement on September 23, 2026, to issue 903,614 pre-funded warrant units at $1.6599 per unit for approximately $1.5 million in gross proceeds. The filing explicitly discloses this as an unregistered private placement under Section 4(a)(2) and Regulation D (Item 3.02), with the investor receiving pre-funded warrants exercisable immediately at $0.0001 per share and common warrants (subject to stockholder approval) exercisable at $1.66 per share. This is a classic dilutive equity issuance by a clinical-stage biopharmaceutical company raising capital for working capital and clinical development activities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-24
The filing discloses results of SkyAI's 2026 Annual Meeting of Stockholders held on September 18, 2026, under Item 5.07. The disclosure reports voting outcomes on four proposals: election of five directors, ratification of PKF O'Connor Davies LLP as independent auditor, rejection of the 2026 Equity Incentive Plan, and rejection of an adjournment proposal. The material aspects include the failed equity plan vote and the auditor ratification, both of which would affect investor assessment of governance and compensation practices.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 45%
filed 2026-09-24
EX-99.1
FBS Global announced a 1-for-10 reverse stock split (share consolidation) approved by shareholders on September 13, 2026, intended to increase per-share trading price to meet Nasdaq's US$1.00 minimum bid price requirement for continued listing. While a reverse split is technically a capital restructuring rather than a dilutive issuance of new equity, it is material to investors as it signals delisting risk and represents a significant corporate action affecting share structure and trading. The disclosure emphasizes the split is conditional on Nasdaq clearance and directly addresses compliance with listing standards.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-09-24
EX-99.1
This exhibit announces a 160-for-1 share consolidation approved by shareholders at an extraordinary general meeting on September 3, 2026, effective September 28, 2026. The consolidation reduces outstanding shares from 375.4 million to approximately 2.3 million Class A shares and adjusts par value and authorized capital. While not a traditional executive appointment, departure, or compensation matter, this is a material governance event involving shareholder-approved capital restructuring that affects share structure, trading symbol/CUSIP, and warrant/option adjustments. It is clearly governance-related but does not fit the specific named governance categories (exec_appointment, exec_departure, exec_compensation, shareholder_vote_results), making governance_other the appropriate classification.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-24
The filing discloses the launch of Reliability Workplace Solutions, LLC, a wholly owned subsidiary focused on healthcare IT staffing and workforce services. This represents a material operational and strategic expansion into a new market segment, building on the company's existing Maslow Media Group infrastructure. While not a traditional M&A transaction, the creation of a new operating subsidiary with dedicated leadership and market focus constitutes a significant operational initiative that would affect a reasonable investor's assessment of the company's growth strategy and business diversification.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-24
The filing discloses entry into a Warrant Repurchase Cancellation and Release Agreement (Item 1.01) whereby Chaince Digital repurchased and permanently canceled all outstanding warrants for US$2.0 million in cash on September 21, 2026. While this involves a material definitive agreement and capital deployment, it does not fit the specific categories of debt_issuance, dilutive_issuance, or dividend_distribution. The transaction eliminates potential share dilution and represents a financial restructuring of the company's capitalization, making it a material financial event best classified as financial_other.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-24
The filing discloses entry into a definitive agreement for the sale of substantially all assets of Printstock Products Limited (a subsidiary business unit) to TAG Investments Limited for NZ$2,450,000 (approximately US$1,400,000) in cash, with closing expected November 20, 2026. This is a material disposition of a business unit disclosed under Item 1.01 (Entry Into a Material Definitive Agreement), representing a strategic divestiture consistent with the company's stated focus on financial services.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
The 8-K discloses fiscal year 2026 financial results for AtlasClear Holdings via a press release dated September 23, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The filing reports significant metrics including 85% revenue growth to $20.1 million, positive GAAP net income of $2.0 million for the second consecutive year, cash doubling to $15.4 million, and resolution of going-concern doubts. This is a material earnings disclosure affecting investor assessment of the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-24
NexGel disclosed on September 24, 2026 that it "began utilizing a new shareholder update presentation entitled 'Strategic Review & Proposed Platform Reorganization'" under Item 7.01 (Regulation FD Disclosure). The language "Strategic Review & Proposed Platform Reorganization" signals a material operational or strategic restructuring initiative, though the 8-K body itself provides limited detail. This appears to be an operational/strategic business event that does not fit a more specific category (e.g., it is not a completed M&A transaction, workforce reduction with quantified charges, or other named type), making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-09-24
The filing discloses a change in the registrant's independent accountant under Item 4.01. HoganTaylor LLP was dismissed on September 20, 2026, and Ernst & Young was engaged as the new auditor effective September 23, 2026, following Audit Committee approval and a competitive selection process. The disclosure includes the required regulatory language regarding disagreements and reportable events, noting a material weakness previously disclosed in the 10-K filed March 31, 2026.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-09-24
Item 5.02
Beyond Air formalized executive compensation arrangements on September 23, 2026, including a new employment agreement with CEO Robert Goodman establishing a base salary of $650,000+, annual bonus target of 60% of base salary, severance provisions (12 months base salary, or 24 months if within a Change in Control window), and equity participation. Additionally, CFO Daniel Moorhead's base salary was increased from $325,000 to $463,000.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-24
The filing discloses an unregistered sale of 234,251,400 common shares (20% of aggregate note principal) to four noteholders in exchange for maturity extensions of secured promissory notes. The transaction is explicitly disclosed under Item 3.02 (Unregistered Sales of Equity Securities) and relies on Section 4(a)(2) and Regulation D exemptions. This represents a highly dilutive equity issuance to settle debt obligations, characteristic of financial distress at a micro-cap company (stock price $0.0009).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-24
SafeSpace Global entered into an equity line of credit (ELOC) providing up to $10 million in equity financing capacity and a convertible note for up to $1 million, both with Crom Structured Opportunities Fund I, LP. The ELOC allows the Company to issue newly issued common shares on a pro rata basis over 36 months, and the convertible note is convertible into common stock. These are classic dilutive equity issuances—unregistered sales of equity securities under Section 4(a)(2) of the Securities Act—that would materially dilute existing shareholders and represent a significant capital raise for the company.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-09-24
EX-99.1
This exhibit is a Secured Convertible Bridge Loan Agreement dated September 20, 2026, between Apex Innovation Global Limited (Lender) and Currenc Group Inc. (Borrower) for a US$1,500,000 facility. The agreement creates a new direct financial obligation—a convertible bridge loan with defined terms including interest (1% per annum), maturity (18 months or upon RTO completion), conversion rights, and security provisions. This is a material debt issuance that would affect a reasonable investor's assessment of the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-09-24
The filing's primary content is Item 5.07, which discloses the results of the 2026 Annual Meeting of Shareholders held on September 23, 2026. The filing reports voting results on four proposals: election of seven directors, approval of potential issuance of 20% or more of outstanding common stock in connection with a debt-financing transaction, amendment to the Omnibus Incentive Compensation Plan, and ratification of the independent auditor. While Item 5.02(e) also addresses the compensatory arrangement (Incentive Plan amendment), the filing's structure and emphasis center on the shareholder vote results and their outcomes, making shareholder_vote_results the primary event type. The debt-financing approval is material as it involves potential dilutive issuance contingent on default.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-24
Glucotrack entered into a securities purchase agreement on September 24, 2026, to issue 169,388 shares of common stock at $2.04 per share and pre-funded warrants to purchase 1,350,220 additional shares at $2.039 per warrant, generating approximately $3.1 million in gross proceeds. This is a registered direct offering of equity securities that will dilute existing shareholders, with the company intending to use proceeds to pay off debt and for working capital. The filing explicitly discloses lock-up agreements and lock-up restrictions on variable rate transactions, which are hallmarks of dilutive equity issuances.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 25%
filed 2026-09-24
EX-99.1
This is a Notice of Extraordinary General Meeting (EGM) calling for a shareholder vote on multiple material proposals, including a major acquisition of Resulticks (Proposal 1), a change of control (Proposal 2), share capital changes (Proposal 3), share consolidation (Proposal 4), and equity plan amendments (Proposal 6). However, this is the notice *calling* the meeting and soliciting votes, not the *results* of a vote. The shareholder_vote_results type is intended for disclosure of voting outcomes after a meeting has occurred. This exhibit is a pre-meeting notice and proxy solicitation, which does not fit cleanly into the taxonomy—it is governance-related but is neither a discrete event (like an appointment or departure) nor a vote result. The underlying transaction (acquisition of Resulticks) is material and would normally be classified as ma_activity, but the exhibit itself is the notice calling the vote, not the transaction approval or completion.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-24
The filing discloses Item 5.02 compensation arrangements for three named executives (CEO Justin Kenna, COO Amaree Vichairattanawong, and CFO Michael Munoz), including acceleration of vesting on previously granted RSUs and stock options, plus new discretionary equity awards (RSUs and options) that vested immediately upon grant on September 18, 2026. This is a material executive compensation event affecting the total mix of information about the registrant's capital structure and executive incentives.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-24
The filing discloses the appointment of Timothy Goldsmith as a director and Audit Committee Chair effective September 24, 2026. While the Item 5.02 section also mentions compensatory arrangements and other committee changes, the principal disclosed action is Goldsmith's appointment to the board and his assumption of the Audit Committee Chair role. The press release emphasizes his appointment as the headline event and notes his extensive audit and SEC reporting experience is critical to BOXABL's governance infrastructure as a newly public company.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-09-24
The Board approved issuance of 1,980,000 Class A and 500,000 Class C ordinary shares to 6 directors and officers "as part of their remuneration packages in fiscal year 2027." This is a compensatory arrangement involving equity grants to named executives, which falls squarely within exec_compensation. The materiality is supported by the aggregate share count (2.48 million shares) and the explicit characterization as remuneration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-24
Item 8.01
News Corporation disclosed daily buy-back notifications to the ASX under its $1 billion repurchase program authorized July 15, 2025. The Item 8.01 disclosure reports that on September 24, 2026, the Company purchased 12,359,711 Class A shares and 62,323 Class B shares for approximately US$325.2 million combined, with approximately US$496.3 million spent to date under the program. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution taxonomy as a return-of-capital mechanism.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-24
Item 1.01
PROCEPT entered into a Third Amendment to its Loan and Security Agreement with CIBC on September 23, 2026, extending the Term Loan Maturity Date by 12 months from October 1, 2027 to October 1, 2028. While this is technically an amendment to existing debt rather than a new issuance, it represents a material modification of a direct financial obligation that extends the company's debt repayment timeline and would be of interest to investors assessing the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-24
Item 7.01
Vertiv announced execution of a definitive agreement to acquire King Environmental Services Ltd., a Europe-based fluid management services provider. The acquisition is expected to close in Q4 2026 and represents a material strategic expansion into EMEA, building on the company's 2025 acquisition of PurgeRite. This is a classic M&A activity disclosure under Item 7.01 (Regulation FD), with the press release furnished as Exhibit 99.1 describing the transaction's strategic rationale and expected benefits.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
Item 2.02
TD SYNNEX issued a press release on September 24, 2026 disclosing financial results for fiscal Q3 2026 ended August 31, 2026, including revenue of $21.6 billion (up 37.7% YoY), operating income of $643 million (up 67.6% YoY), and diluted EPS of $5.18 (up 89.1% YoY). The filing also announces a quarterly dividend of $0.48 per share. This is a standard quarterly earnings release with material financial results that would affect a reasonable investor's assessment of the company's performance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-24
Item 8.01
Vistagen disclosed positive exploratory efficacy data for fasedienol nasal spray presented at Psych Congress 2026, showing statistically significant improvements in anxiety symptoms in subpopulation analyses of participants with very severe social anxiety disorder. This represents a material clinical development milestone for the Company's Phase 3 product candidate, affecting investor assessment of pipeline progress and regulatory prospects, but does not fit the specific categories of earnings release, exec changes, M&A, impairment, or other named event types. The disclosure is operational/strategic in nature—a clinical trial result announcement—and material to a biopharmaceutical company's valuation and development trajectory.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-24
Item 5.02
Michael Akkerman, Chief Business Officer, resigned his position effective October 30, 2026, to accept a CEO role elsewhere. This is a clear executive departure of a named officer. The disclosure centers on the departure action itself rather than any appointment or compensation arrangement, making exec_departure the appropriate classification.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-24
Item 7.01
Infleqtion announced achievement of 30 entangled logical qubits on its Sqale quantum computer, a key 2026 roadmap milestone. This is a material operational/technical achievement that demonstrates progress toward commercialization of quantum computing technology and validates the company's hardware and software architecture. While disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated 8-K item, the announcement of a significant product milestone with customer applications and clear roadmap implications would affect a reasonable investor's assessment of the company's technical progress and commercial viability.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-24
Item 5.02
Dr. Brenda Cooperstone resigned from the Board of Directors and her position as Chair of the Compensation Committee, effective immediately on September 23, 2026. The disclosure centers on a director's departure rather than an appointment or compensation arrangement. Board departures, particularly of committee chairs, are material to investors as they affect governance and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-24
Item 5.02
Tony Weisman was appointed as a Class I director of Ibotta effective September 22, 2026, and assigned to the Audit Committee. Weisman brings 30+ years of CPG marketing leadership and prior board experience at public companies including Klaviyo and MNTN.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-24
Item 7.01
Ellington Financial announced its estimated book value per share of $13.62 as of August 31, 2026, along with a monthly dividend of $0.13 per share. This is a financial disclosure of net asset value and dividend information material to shareholders of a mortgage REIT, but does not fit the specific categories of earnings_release (which typically refers to full quarterly/annual results), dividend_distribution (which focuses on declaration/payment of dividends rather than NAV announcements), or other named financial event types. The disclosure is clearly financial in nature and material to investors assessing the registrant's value.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-24
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.08 per share by the Board of Directors, payable October 29, 2026 to shareholders of record as of October 14, 2026. This is a straightforward dividend distribution event that would be material to investors assessing the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-24
EX-99.1
This press release announces that HUTCHMED will present clinical data from multiple studies at the ESMO Congress 2026, including positive Phase III results from the SAFFRON and SANOVO studies evaluating savolitinib and osimertinib combination therapy. The disclosure highlights two late-breaking abstracts selected for oral presentations at a major medical conference, demonstrating clinical progress in the company's pipeline. While not a discrete M&A, financial, or governance event, this represents a material operational/clinical milestone that would affect investor assessment of the company's drug development progress and commercial prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-24
Item 5.07
This Item 5.07 disclosure reports the results of BayFirst Financial Corp.'s 2026 Annual Meeting of Shareholders held on September 22, 2026, including voting results for the election of 12 directors and an adjournment proposal. The filing presents detailed vote tallies (shares voted for, withheld, and abstentions/broker non-votes) for each nominee, which is the core content of a shareholder vote results disclosure. Director elections are material governance events affecting the composition of the board.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-24
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $510 million (a $500M callable bond and a $10M non-callable bond) by the Federal Home Loan Bank of New York. Item 2.03 explicitly covers creation of direct financial obligations, and Schedule A details specific debt securities issued on trade dates in September 2026 with defined maturity dates, coupon rates, and call provisions. This is a material debt issuance event.
View raw filing on EDGAR →